Article Details
Retrieved on: 2024-07-05 13:43:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities analyst Nicole Germino maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $68 to $88. 7/1/24 8:49:49 AM ET.
Article found on: quantisnow.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here